GlaxoSmithKline
GSK
#258
Rank
NZ$130.22 B
Marketcap
$63.81
Share price
0.22%
Change (1 day)
-5.97%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.67

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $6.10. In 2022 the company made an earnings per share (EPS) of $14.77 an increase over its 2021 EPS that were of $5.21.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.67-61.59%
2022$14.77183.39%
2021$5.21-17.83%
2020$6.3421.82%
2019$5.2123.91%
2018$4.20141.48%
2017$1.7464.6%
2016$1.06-90.64%
2015$11.29178.14%
2014$4.06-48.16%
2013$7.8322.63%
2012$6.39-11.32%
2011$7.20230.25%
2010$2.18-70.98%
2009$7.526.76%
2008$7.04-15.14%
2007$8.307.82%
2006$7.6919.61%
2005$6.4318.56%
2004$5.430.36%
2003$5.4150.39%
2002$3.5931.13%
2001$2.74-25.43%
2000$3.6831.58%
1999$2.791.05%
1998$2.76-0.98%
1997$2.79-10.07%
1996$3.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.46-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.24-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.17-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.51 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.54-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.48-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.52-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA